HIF1A and neoplasm: A significant decrease was observed in cells silenced for β-arr1 or HIF-1α, or treated with macitentan (Figure 4B, 4C), indicating that tumor cells require the association of HIF-1α with β-arr1 for a full transcriptional response to ET-1/ETAR axis.